Bacillus subtilis 14119 that produced inosine and guanosine or Bacillus subtilis AG 169 that produced xanthosine and guanosine was mutated to resistance against sulfaguanidine. Among the mutants derived, those that showed the increased production of guanosine were observed frequently.
per liter of the culture broth at weight yields of 13.8 and 12.5 % from consumed sugar, re spectively.
In these strains, the specific activity of GMP synthetase was higher than that of the parental strain, and furthermore in T104, that of IMP dehydrogenase also was higher. Thus, it is speculated that the metabolic flow from XMP to GMP, especially in T104 from IMP to XMP too, proceeds smoothly and yields more guanosine.
On the microbial production of guanosine so far, there have been many studies. Recently, it has been shown by the authors5) (Table III) . Furthermore, growth inhibition of these strains by sulfaguanidine was investigated (Fig. 1) . Mutants T104 and GS-1 were slight ly more resistant to sulfaguanidine than the parents 14119 and AG169, respectively, but not completely resistant.
Properties of the enzymes relating to the con version of IMP to GMP in sulfaguanidine resistant mutants The guanosine productivity of the sulfa guanidine resistant mutants, T104 and GS-1, increased as shown in Table III . From the facts, it is imagined that the enzymes relating to the conversion of IMP to GMP are varied in these mutants. Therefore, the four enzymes of IMP dehydrogenase, GMP synthetase, 5'-nucleotidase and glutamine synthetase were assayed. IMP dehydrogenase converts IMP to XMP. The specific activity of this enzyme in the sul faguanidine resistant mutant T104 increased when compared with that of the parent 14119. But no difference could be found between mutant GS-1 and the parent AG169. Inhi bition of the enzyme activity by 0.55 mm GMP was not observed in any of the four strains. The results are presented in Table IV . The specific activity of this enzyme in the sulfaguanidine resistant mutants, T104 and GS-1, increased about three times and two times of that of the parents, 14119 and AG169, respectively. Inhibition of the enzyme activity by GMP was not ob served at 0.6 mm GMP, but at the high level of 4 mm GMP in all of the four strains. The results are presented in Table V. 5'-Nucleotidase forms nucleoside and inor ganic phosphate, degrading 5'-nucleotide. 5'-IMP, 5'-XMP and 5'-GMP, here, were used as substrates of 5'-nucleotidase.
Although the specific activities of AG169 and GS-1 were remarkably lower than those of 14119 and T104, variations of the specific activity between mutants and the parents could not be re cognized at all (Table VI) . Glutamine synthetase forms glutamine from glutamic acid, ammonia and ATP. And the glutamine is used as the substrate of GMP synthetase in part. The specific activity of this enzyme in the sulfaguanidine resistant mutant T104 decreased slightly in comparison with the parent 14119, but no difference could be found between mutant GS-1 and the parent AG 169 (Table VII) . In the case of T104, the following multiple variations were caused that the specific ac tivities of IMP dehydrogenase and GMP synthetase were higher than those of the parent 14119, and the specific activity of glutamine synthetase was slightly lower. 5'-Nucleo tidase did not vary. As the results, IMP is readily converted to GMP by way of XMP, and increased production of guanosine was found.
Furthermore, T104 did not decrease the inosine formation, but increased the pro duction of total purine nucleosides (Table III) . Namely, in T104, the sulfaguanidine resistance seems to strengthen the metabolic flow to IMP biosynthesis, too. However, though overcome by p-aminobenzoic acid, growth inhibitions of strains 14119 and AG169 by sulfaguanidine were not reversed by adding hypoxanthine, xanthine, guanine and folic acid (Table I , data not shown in AG169). At present, we are unable to clarify why the sulfaguanidine re sistance causes the increases of specific activity in GMP synthetase and IMP dehydrogenase, and the elevation of IMP biosynthetic pathway. Perhaps the mode of action of sulfaguanidine may be multiple.
